Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Genes|December 19, 2020
Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for PharmacogeneticsLaura M de Jong, Wim Jiskoot, Jesse J Swen, et al.
Pharmacogenomics|December 21, 2012
Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexateCristina Lucía Dávila-Fajardo, Jesse J Swen, José Cabeza Barrera, et al.
Clinical Pharmacokinetics|May 31, 2013
The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugsN van Leeuwen, J J Swen, H-J Guchelaar, et al.
Frontiers in Pharmacology|September 13, 2021
Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical PracticeAlireza Tafazoli, Henk-Jan Guchelaar, Wojciech Miltyk, et al.
Pharmacogenomics|May 2, 2015
GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian populationPaul C D Bank, Jesse J Swen, Henk-Jan Guchelaar, et al.
Clinical Chemistry and Laboratory Medicine|October 26, 2011
Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β geneJesse J Swen, Renee F Baak-Pablo, Henk-Jan Guchelaar, et al.
Clinical Pharmacology and Therapeutics|November 28, 2025
Long-Read Sequencing Enhances Pharmacogenomic Profiling by Resolving Complex Haplotypes, Novel Star Alleles, and Structural VariantsSumudu Rangika Samarasinghe, Andrea Gaedigk, Jesse J Swen, et al.
The Pharmacogenomics Journal|October 19, 2019
Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic reviewFrank Eektimmerman, Jesse J Swen, Moenira B Madhar, et al.
Pharmacogenomics|May 17, 2016
Evaluation of clinical implementation of prospective DPYD genotyping in 5-fluorouracil- or capecitabine-treated patientsCarin Atc Lunenburg, Maurice C van Staveren, Hans Gelderblom, et al.
Pharmacogenomics|April 28, 2018
SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patientsFrank Eektimmerman, Jesse J Swen, Stefan Böhringer, et al.
Pageof 19